14th EDRN Scientific Workshop

The Early Detection Research Network (EDRN) will host its 14th EDRN Scientific Workshop "Unleashing the Power of Collaboration: The Future Is Here" from Tuesday-Thursday, March 4-6, 2025 at the DoubleTree by Hilton Washington DC North/Gaithersburg Hotel (in-person only)

Meeting Registration, Hotel Rooms and Poster Abstracts

Meeting Registration: Registration is mandatory to attend this event. Fill out this registration form to register easily online. Please be complete and accurate when completing this form—especially your email address. The deadline to register is Monday, February 24, 2025.
Hotel Rooms: EDRN has a block of sleeping rooms at the DoubleTree by Hilton Washington DC North/Gaithersburg hotel. The rate for all attendees is $276/night plus taxes. The deadline to book your room is Tuesday, February 11, 2025 or until the room block is full.
- Complete booking online
- To book by phone dial 301-977-8900--use Group Code CDT14T or 14th Scientific Workshop.
Poster Abstracts: The poster session is on Wednesday, March 5th starting with lightning presentations at 10:00 a.m. EDRN Principal Investigators must present a poster at this event. Other attendees are strongly encouraged to present a poster. Please submit your poster abstract to the EDRN DMCC at edrndmcc@fredhutch.org by Tuesday, February 4, 2025. Formatting specifications for poster abstracts and poster board dimensions are available.

Schedule of Events (all times Eastern Standard Time)

(Times of events are subject to change)

Date	Time	Topic	Materials
Tuesday, March 4, 2025	7:00 a.m. – 8:00 a.m.	Day 1: Sign-in (Breakfast is Complimentary for Hotel Guests, $20 for other attendees) Room: TBD	📜Main Agenda-DRAFT (forthcoming)
Tuesday, March 4, 2025	8:00 a.m. – 8:10 a.m.	Day 1: Welcome Room: TBD Sudhir Srivastava, PhD, MPH, Chief Program Officer, Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute Opening Remarks from Workshop Planning Chairs: Cecilia Yeung, MD, Fred Hutchinson Cancer Center James Willey, MD, University of Toledo College of Medicine	📜Day 1 Agenda-DRAFT (forthcoming)
Tuesday, March 4, 2025	8:10 a.m. – 8:30 a.m.	Day 1: Keynote Address: Philip E. Castle, PhD, MPH, Director, Division of Cancer Prevention, National Cancer Institute	📜Day 1 Agenda-DRAFT (forthcoming)
Tuesday, March 4, 2025	8:30 a.m. – 8:50 a.m.	Day 1: Keynote Address: Jennifer Webster-Cyriaque, DDS, PhD, Deputy Director, National Institute of Dental and Craniofacial Research, National Institutes of Health	📜Day 1 Agenda-DRAFT (forthcoming)
Tuesday, March 4, 2025	8:50 a.m. – 10:30 a.m.	Day 1: Session 1: Unraveling the Power of Spatial Genomics and digital pathology toward Biomarker Discovery: analytical and clinical validation and harmonization? (Jointly by EDRN and PreCancer Atlas Investigators--4 presenters) Room: TBD Chair/Co-chair: Cecilia Yeung, MD, Fred Hutchinson Cancer Center Irene Ghobrial, MD, Dana-Farber Cancer Institute/Harvard Medical School	📜Day 1 Agenda-DRAFT (forthcoming)
Tuesday, March 4, 2025	10:30 a.m. – 11:00 a.m.	Day 1: Networking Break	N/A
Tuesday, March 4, 2025	11:00 a.m. – 12:15 p.m.	Day 1: Session 2: Demystifying Data Science Applications in Multi-Modal Biomarker Development and Validation (3 presenters) Room: TBD Chair/Co-Chair: Jennifer Beane, PhD, Boston University School of Medicine Dan Crichton, MA, NASA Jet Propulsion Laboratory	📜Day 1 Agenda-DRAFT (forthcoming)
Tuesday, March 4, 2025	12:15 p.m. – 1:30 p.m.	Day 1: Lunch (On Your Own or Complimentary for Hotel Guests)	N/A
Tuesday, March 4, 2025	1:30 p.m. – 2:45 p.m.	Day 1: Session 3: Liquid Biopsy Analytical and Clinical Validation and Harmonization (Jointly by EDRN BRL and LBC-3 presenters) Room: TBD Chair/Co-chair: Jeff Tosoian, MD, Vanderbilt University Medical Center Nickolas Papadopoulos, PhD, Johns Hopkins University	📜Day 1 Agenda-DRAFT (forthcoming)
Tuesday, March 4, 2025	2:45 p.m. – 3:15 p.m.	Day 1: Networking Break	N/A
Tuesday, March 4, 2025	3:15 p.m. – 4:30 p.m.	Day 1: Session 4: Unleashing the Power of Imaging and Radiomics (3 presenters) Room: TBD Chair/Co-chair: Matt Schabath, PhD, H. Lee Moffitt Cancer Center and Research Institute, Inc. Anirban Maitra, MBBS, The University of Texas MD Anderson Cancer Center	📜Day 1 Agenda-DRAFT (forthcoming)
Tuesday, March 4, 2025	4:30 p.m. – 5:00 p.m.	Day 1: Panel Discussion for Sessions 1-4: Biomarker Development Room: TBD Chair/Co-chair: David Sidransky, MD, Johns Hopkins School of Medicine David Wong, DMD, DMSC, University of California, Los Angeles	📜Day 1 Agenda-DRAFT (forthcoming)
Tuesday, March 4, 2025	5:00 p.m. – 5:30 p.m.	Day 1: Forum Discussion Room: TBD	📜Day 1 Agenda-DRAFT (forthcoming)
Wednesday, March 5, 2025	7:00 a.m. – 8:00 a.m.	Day 2: Sign-in (Breakfast is Complimentary for Hotel Guests, $20 for other attendees) Room: TBD	📜Day 2 Agenda-DRAFT (forthcoming)
Wednesday, March 5, 2025	8:00 a.m. – 8:30 a.m.	Day 2: Keynote 3 Speaker Room: TBD	📜Day 2 Agenda-DRAFT (forthcoming)
Wednesday, March 5, 2025	8:30 a.m. – 9:45 a.m.	Day 2: Session 5: Best Practices for Biomarker Discovery and Development (3 Presenters) Room: TBD Chair/Co-Chair: James Willey, MD, University of Toledo College of Medicine Gerard Davis, PhD, Abbott Laboratories	📜Day 2 Agenda-DRAFT (forthcoming)
Wednesday, March 5, 2025	9:45 a.m. – 10:00 a.m.	Day 2: Break	N/A
Wednesday, March 5, 2025	10:00 a.m. – 11:00 a.m.	Day 2: Poster Lightening Presentations (6 presentations) Room: TBD	📜Day 2 Agenda-DRAFT (forthcoming)
Wednesday, March 5, 2025	11:00 a.m. – 12:30 p.m.	Day 2: Poster Session	📜Day 2 Agenda-DRAFT (forthcoming)
Wednesday, March 5, 2025	12:30 p.m. – 2:00 p.m	Day 2: Lunch (On Your Own or Complimentary for Hotel Guests)	N/A
Wednesday, March 5, 2025	2:00 p.m. – 3:00 p.m.	Day 2: Session 6: Novel biomarker discovery technology and late breaking abstracts: Flash Talks for Selected Abstracts (5-min each) and Consortia (EDRN, PCDC, PCA, TBEL, LB, TLC) ESI Presentations (3 Presentations)	📜Day 2 Agenda-DRAFT (forthcoming)
Wednesday, March 5, 2025	3:00 p.m. – 4:30 p.m.	Day 2: Session 7: Biobanks: Fueling The Multi-Omics Approaches For Biomarker Discovery (Introductions and 3 Presentations) Room: TBD Chair/Co-chair: Stephen Deppen, MD, PhD, Vanderbilt University Medical Center Randy Brand, MD, University of Pittsburgh	📜Day 2 Agenda-DRAFT (forthcoming)
Thursday, March 6, 2025	7:00 a.m. – 8:00 a.m.	Day 3: Sign-in (Breakfast is Complimentary for Hotel Guests, $20 for Other Attendees) Room: TBD	N/A
Thursday, March 6, 2025	8:00 a.m. – 8:30 a.m.	Day 3: Plenary Talk Room: TBD	📜Day 3 Agenda-DRAFT (forthcoming)
Thursday, March 6, 2025	8:30 a.m. – 9:45 a.m.	Day 3: Session 8: Clinical Utility Trials: Clinical Utility Assessment with focus on the Efforts of the Cancer Screening Network, Including Both MCEDs and Single Cancer Biomarkers (3 Presentations) Room: TBD Chair/Co-chair: Elyse Leevan, MD, MPH, National Cancer Institute Bob Bresalier, MD, The University of Texas MD Anderson Cancer Center	📜Day 3 Agenda-DRAFT (forthcoming)
Thursday, March 6, 2025	9:45 a.m. – 10:15 a.m.	Day 3: Panel Discussion Suggestions for Session 8: Regulatory and Reimbursement Considerations	📜Day 3 Agenda-DRAFT (forthcoming)
Thursday, March 6, 2025	10:15 a.m. – 10:30 a.m.	Day 3: Closing and Final Remarks Sudhir Srivastava, PhD, MPH, National Cancer Institute	📜Day 3 Agenda-DRAFT (forthcoming)